These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7901147)

  • 1. Graft vessel disease: the impact of immunosuppression and possible treatment strategies.
    Meiser B; Reichart B
    Immunol Rev; 1993 Aug; 134():99-116. PubMed ID: 7901147
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model.
    Meiser BM; Wolf S; Devens C; Wenke K; Thiery J; Kreuzer E; Hammer C; Billingham ME; Reichart B
    Transplant Proc; 1992 Oct; 24(5):1671-2. PubMed ID: 1384201
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model.
    Meiser BM; Wenke K; Thiery J; Wolf S; Devens C; Seidel D; Hammer C; Billingham ME; Reichart B
    Transplant Proc; 1993 Apr; 25(2):2077-9. PubMed ID: 7682363
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
    Hisatomi K
    Transplant Proc; 1998 Dec; 30(8):4337-9. PubMed ID: 9865378
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection.
    Paul LC; Davidoff A; Benediktsson H; Issekutz TB
    Transplantation; 1993 May; 55(5):1196-9. PubMed ID: 8497903
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
    Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R
    Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat.
    Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog.
    Wahlers T; Mügge A; Oppelt P; Heublein B; Fieguth HG; Jurmann M; Haverich A
    Transplant Proc; 1994 Oct; 26(5):2741-2. PubMed ID: 7940860
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention and treatment of graft vessel disease after heart transplantation.
    Meiser BM; Wenke K; Thiery J; Brandl U; Mair H; Kur F; Detter C; Uberfuhr P; Kreuzer E; Seidel D
    Transplant Proc; 1995 Jun; 27(3):1931-5. PubMed ID: 7792841
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of antiplatelet drugs on graft atherosclerosis in rat heterotopic cardiac allografts.
    Muskett A; Burton NA; Eichwald EJ; Shelby J; Hendrickson M; Sullivan JJ
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):74-6. PubMed ID: 3303572
    [No Abstract]   [Full Text] [Related]  

  • 11. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial.
    Wenke K; Meiser B; Thiery J; Nagel D; von Scheidt W; Steinbeck G; Seidel D; Reichart B
    Circulation; 1997 Sep; 96(5):1398-402. PubMed ID: 9315523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD26/DPP IV-mediated modulation of acute rejection.
    Korom S; De Meester I; Coito AJ; Graser E; Pratschke J; König S; Grimm H; Volk HD; Scharpé S; Kupiec-Weglinski JW
    Transplant Proc; 1999; 31(1-2):873. PubMed ID: 10083382
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship between acute rejection and chronic rejection is highly dependent on specific MHC matching: a multi-strain rat heterotopic heart transplant study.
    Hosenpud JD; Boyle TM; Hensler H; Sanford G; Khanna AK
    Transplantation; 2000 May; 69(10):2173-8. PubMed ID: 10852619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term angiopeptin therapy and the incidence of graft vessel disease after heart transplantation.
    Meiser BM; Mueller M; Foegh M; Von Scheidt W; Reichart B
    J Heart Lung Transplant; 2002 Dec; 21(12):1264-73. PubMed ID: 12490271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract]   [Full Text] [Related]  

  • 16. Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible?
    Wenke K; Meiser B; Thiery J; Arndtz N; von Scheidt W; Seidel D; Reichart B
    Transplant Proc; 1995 Jun; 27(3):1954-5. PubMed ID: 7792848
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
    Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham ME; Morris RE
    Transplant Proc; 2001 May; 33(3):2170-1. PubMed ID: 11377490
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
    Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
    [No Abstract]   [Full Text] [Related]  

  • 20. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.